Drug Profile: Nebivolol + Valsartan

Introduction (English)

Nebivolol + Valsartan is a fixed-dose combination used in the management of hypertension. It combines a beta-blocker (Nebivolol) with an angiotensin II receptor blocker (Valsartan) to provide dual blood pressure control.

Class

Nebivolol: Beta-1 selective adrenergic blocker with nitric oxide–mediated vasodilatory properties.
Valsartan: Angiotensin II receptor blocker (ARB).

Purpose

Used to lower high blood pressure and reduce cardiovascular risk in patients with hypertension.

Mechanism of Action

Nebivolol: Blocks beta-1 receptors, reducing heart rate and cardiac output; also promotes vasodilation via nitric oxide release.
Valsartan: Blocks angiotensin II receptors, preventing vasoconstriction and reducing aldosterone-mediated sodium retention.
Together: Provide synergistic blood pressure reduction and vascular protection.

Advantages

Dual mechanism for better blood pressure control.
Reduces risk of stroke, heart attack, and heart failure progression.
Convenient fixed-dose combination improves compliance.
Nebivolol’s vasodilatory effect may improve tolerability compared to older beta-blockers.

Dose & Form

Oral tablets (various strengths combining Nebivolol and Valsartan).
Dose individualized based on patient’s blood pressure and physician’s advice.